Selective induction of an embryonic fibronectin isoform in the rat aorta in vitro.

The temporal changes in the expression of fibronectin and other extracellular matrix genes were studied in rat aortic rings incubated in vitro in a serum-free medium. Changes in all forms of fibronectin mRNA increased progressively during the 24-hour incubation period, although an increase in the alternatively spliced form of fibronectin designated EIIIA was most pronounced. Both collagen and elastin mRNA levels decreased markedly during the 24-hour interval, as did alpha-actin mRNA. The increase in the relative amount of the EIIIA isoform after a 24-hour incubation was also shown using ribonuclease protection assays. In situ hybridization showed the distribution of the induced fibronectin mRNA to be within all cell types, including endothelial cells, medial smooth muscle cells, and adventitial fibroblasts. Localization in the media was not uniform and was clearly identified mainly in clusters of cells distributed throughout the media. The early induction of fibronectin mRNA was inhibited by genistein, implicating tyrosine kinase activation as a causative factor in fibronectin expression. The in vitro changes reported may reflect a phenotypic change in vascular cell types that is both similar to and different from the changes reported in vivo under conditions in which vascular injury and repair occur.

[1]  A. Chobanian,et al.  Age-related changes in fibronectin expression in spontaneously hypertensive, Wistar-Kyoto, and Wistar rat hearts. , 1992, Circulation research.

[2]  M. Pazin,et al.  Triggering signaling cascades by receptor tyrosine kinases. , 1992, Trends in biochemical sciences.

[3]  S. Schwartz,et al.  Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. , 1992, Circulation research.

[4]  A. Chobanian,et al.  Hypertension induces alternatively spliced forms of fibronectin in rat aorta. , 1992, Hypertension.

[5]  P. Brecher,et al.  Fibronectin expression in the normal and hypertrophic rat heart. , 1992, The Journal of clinical investigation.

[6]  S. Schwartz,et al.  Hypertension and atherosclerosis. Cause and effect, or two effects with one unknown cause? , 1991, Circulation.

[7]  J. Thiery,et al.  Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. , 1991, The Journal of clinical investigation.

[8]  A. Chobanian,et al.  Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. , 1991, The Journal of clinical investigation.

[9]  A. Chobanian,et al.  Biosynthesis of fibronectin by rabbit aorta. , 1991, The Journal of biological chemistry.

[10]  A. Chobanian,et al.  Effect of hypertension on fibronectin expression in the rat aorta. , 1990, The Journal of biological chemistry.

[11]  J. Thyberg,et al.  Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.

[12]  V. Koteliansky,et al.  Expression of fibronectin variants in vascular and visceral smooth muscle cells in development. , 1990, Developmental biology.

[13]  A. Chobanian 1989 Corcoran Lecture: Adaptive and Maladaptive Responses of the Arterial Wall to Hypertension , 1990, Hypertension.

[14]  D E Ingber,et al.  Fibronectin controls capillary endothelial cell growth by modulating cell shape. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Nadal-Ginard,et al.  Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. , 1989, The Journal of clinical investigation.

[16]  Harold E. Dvorak,et al.  Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat , 1989, The Journal of cell biology.

[17]  V. Koteliansky,et al.  Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent , 1989, Journal of Cell Biology.

[18]  J. Foster,et al.  Characterization of rat heart tropoelastin. , 1989, Archives of biochemistry and biophysics.

[19]  O. Kocher,et al.  Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin , 1988, The Journal of cell biology.

[20]  G. Sonenshein,et al.  Serum deprivation of vascular smooth muscle cells enhances collagen gene expression. , 1988, The Journal of biological chemistry.

[21]  V. Koteliansky,et al.  Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. , 1987, Atherosclerosis.

[22]  I. Herman,et al.  Regulation of Vascular Smooth Muscle Cell Growth by Endothelial‐Synthesized Extracellular Matrices , 1987, Arteriosclerosis.

[23]  R. Hynes,et al.  Multiple sites of alternative splicing of the rat fibronectin gene transcript. , 1987, The EMBO journal.

[24]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[25]  G. Owens,et al.  Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. , 1986, The Journal of biological chemistry.

[26]  C. Ashall,et al.  Fibronectin distribution in human aortic intima and atherosclerotic lesions: concentration of soluble and collagenase-releasable fractions. , 1986, Biochimica et biophysica acta.

[27]  D. Rowe,et al.  Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. , 1984, Biochemistry.

[28]  V. Tertov,et al.  Content and localization of fibronectin in normal intima, atherosclerotic plaque, and underlying media of human aorta. , 1984, Atherosclerosis.

[29]  R. Hynes,et al.  Three different fibronectin mRNAs arise by alternative splicing within the coding region , 1983, Cell.

[30]  S. Farmer,et al.  Regulation of tubulin and actin mRNA production in rat brain: expression of a new beta-tubulin mRNA with development. , 1983, Molecular and cellular biology.

[31]  R. Clark,et al.  Fibronectin is produced by blood vessels in response to injury , 1982, The Journal of experimental medicine.

[32]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[33]  E. Ruoslahti Fibronectin and its receptors. , 1988, Annual review of biochemistry.

[34]  M. Buckingham,et al.  Transcripts of a-cardiac and a-skeletal actins are early markers for myogenesis in the mouse embryo , 2022 .